-
FDA Advisory Panel Backs Vivus’s Qnexa
22 Feb 2012 | 4:41 pm
Read more...
The second time’s a charm for Vivus’s experimental obesity drug Qnexa, at least when it comes to FDA advisory panel votes.
As the WSJ reports, one of the agency’s advisory panels today backed approval of the drug by a decisive[…] -
Newly Approved Drug for Metastatic Melanoma Nearly Doubles Median Survival
22 Feb 2012 | 4:00 pmResearchers from UCLA’s Jonsson Comprehensive Cancer Center, together with scientists from 12 other sites in the United States and Australia, report for the first time that a newly approved drug for patients with metastatic melanoma nearly doubles median survival times,[…]
Read more... -
Feds Announce U.S. Alzheimer’s Plan, But Will it Have an Impact?
22 Feb 2012 | 3:50 pm
Read more...
The Department of Health and Human Services unveiled Wednesday the first draft of a national action plan against Alzheimer’s disease, which aims to come up with effective treatment and prevention strategies by 2025.
The plan, much anticipated by many in[…] -
Migraines may raise depression risk in women
22 Feb 2012 | 3:19 pm
Read more...Middle-aged women are roughly 40% more likely to become depressed if they experience migraine headaches, new research suggests.
-
Fructose Doesn’t Make You Gain Weight (Unless You Eat Too Much Of It)
22 Feb 2012 | 3:15 pm
Read more...
Fructose has been accused of all sorts of health-related sins, from high blood pressure to diabetes to obesity.
“Classical biochemistry teaching” that shows fructose is metabolized differently than glucose as well as rodent studies showing that a high-fructose diet can[…] -
FDA to review safety of caffeine powder
22 Feb 2012 | 9:01 am
Read more...Food and Drug Administration officials plan to investigate whether a form of caffeine sold in lipstick-shaped containers is safe for consumers.
-
A.M. Vitals: Chavez to Have Third Operation
22 Feb 2012 | 8:14 am
Read more...
Another Cancer Surgery For Chavez: Venezuelan President Hugo Chavez will have a lesion surgically removed from his pelvis within the next few days, the WSJ reports. Chavez, who has already undergone two other surgeries for cancer, claimed the disease hadn’t[…] -
Crash test dummy unveiled for larger children
21 Feb 2012 | 5:43 pm
Read more...The National Highway Traffic Safety Administration on Tuesday unveiled a new crash test dummy to be used to evaluate child safety seats and boosters made for children weighing more than 65 pounds.
-
J&J CEO Succession: Who is Alex Gorsky?
21 Feb 2012 | 4:27 pm
Read more...
Alex Gorsky in 2010.
Johnson & Johnson named Alex Gorsky as its next CEO, succeeding William Weldon, the WSJ reports.
Both Gorsky and Sherilyn McCoy were in late 2010 appointed to an expanded “office of the chairman” and given new[…] -
Ironman champ: Train your brain
21 Feb 2012 | 3:41 pm
Read more...Sporting success rests with having the mental fortitude necessary to overcome our fears, pain, and discomfort, Chrissie Wellington says.
-
FDA Announces Steps to Ease Cancer Drug Shortages
21 Feb 2012 | 2:23 pmThe US Food and Drug Administration (FDA) said Tuesday that it is taking steps to increase the supply of 2 cancer drugs on its drug shortage list: liposomal doxorubicin (Doxil )and methotrexate.
Read more... -
Abuse risk high for nonconformists
20 Feb 2012 | 6:15 am
Read more...When a boy struts in a tutu or a girl dons boxer shorts, grown-ups get nervous. It's one of the first lessons gender nonconforming kids learn.
-
PROFILE: Gay Crooks—Exploring the Human Side of Stem Cell Biology
17 Feb 2012 | 3:00 pmFor many scientists who are clinicians and researchers, balancing the demands of both disciplines can often feel more limiting than it is liberating. But for Dr. Gay Crooks, a physician who specializes in bone marrow transplantation for children and young[…]
Read more... -
Manufacturer Releasing Emergency Supplies of Methotrexate
16 Feb 2012 | 3:01 pmA maker of the cancer drug methotrexate, Bedford Laboratories, has advised the FDA that it will release emergency supplies of preservative-free methotrexate to meet patients’ needs.
Read more... -
FDA Warns of Counterfeit Avastin
15 Feb 2012 | 1:14 pmThe US Food and Drug Administration (FDA) is warning that some fake versions of the cancer drug Avastin (bevacizumab) may have been purchased by medical practices.
Read more... -
Radiation Treatments Generate Cancer Stem Cells from Less Aggressive Breast Cancer Cells
14 Feb 2012 | 11:30 amBreast cancer stem cells are thought to be the sole source of tumor recurrence and are known to be resistant to radiation therapy and don’t respond well to chemotherapy. Now, researchers with the UCLA Department of Radiation Oncology at UCLA’s[…]
Read more... -
AUDIO: Dr. Antoni Ribas Talks Potential Treatment Benefits of New Melanoma Drug that Accelerates Less Serious Skin Cancers
13 Feb 2012 | 3:00 pmIn a recent study, UCLA researchers discovered that a newly-approved melanoma drug accelerates secondary skin cancers in some patients. In this radio report from KPCC, listen to Jonsson Comprehensive Cancer Center scientist and co-senior author of the study Dr. Antoni[…]
Read more... -
Kids Can Be Kids at Summer Camps for Children with Cancer
13 Feb 2012 | 10:18 amThe American Cancer Society supports 45 camps for children with cancer. Some camps also welcome brothers and sisters. Most are provided at no cost to families, but space is limited and camps do fill up.
Read more... -
AUDIO: Athena Breast Health Network Launches Forum Series
8 Feb 2012 | 1:30 pmThe Athena Breast Health Network has launched a series of face-to-face forums where patients, breast cancer experts and community members can exchange direct experience and research in breast health care. In this podcast of their inaugural forum, special guests Arash[…]
Read more... -
Study: Additional Treatment Helps Some Patients with Rare Brain Tumor Live Longer
7 Feb 2012 | 12:55 pmIn a clinical trial, adding chemotherapy to radiation nearly doubled the survival time for some patients with a rare brain tumor called oligodendroglioma.
Read more...




